AVAX Technologies, AVXT- NASDAQ Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : AVAX Technologies, AVXT- NASDAQ

AVXT 0.00001000

0.0%

Mar 6 3:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: .Trev who wrote (115)	7/23/2000 9:45:39 AM
From: david james	Read Replies (1) of 142

Yes, they announced that the CEO would be on power lunch just after the bell on Friday. cnbc.com It will be quite interesting to see how these Australian sales work out. At $10k to $15k per treatment, how many other people worldwide will pay for a flight down on a treatment that is likely to save your life - or at least double your life expectancy. What is also interesting is that usually in trials, the melanoma must be at relatively late stages. This makes is even more difficult to show positive effects. Since the vaccine shows no serious side effects, we should see a larger distribution using the vaccine in Australia (including those with the cancer at earlier stages). This means that the vaccine is likely to show even better results with this population. With the success of the drug in Australia, it will be interesting to see if this puts pressure on the Australian government to support the use of the drug.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next